This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Citrix Systems, Watson Pharmaceuticals: S&P Gainers

Stocks in this article: CTXS ^GSPC WPI

NEW YORK ( TheStreet) -- Citrix Systems (CTXS - Get Report) and Watson Pharmaceuticals (WPI) were among the best-performing stocks in the S&P 500 on Thursday.

The S&P 500 rose 9.29 points, or 0.67%, to 1,399.98 on Thursday.

Shares of Citrix Systems gained 12.43% to $86.76. On Thursday, the stock was upgraded to outperform by FBR Securities analysts with a $100 price target after a big earnings beat.

The company reported Wednesday after the close first-quarter earnings of 59 cents a share, excluding items, up from year-earlier earnings of 50 cents. On average, analysts expected earnings of 51 cents a share.

First quarter revenue grew 20% to $589 million.

Citrix Systems trades at an estimated price-to-earnings ratio for next year of 27.37X; the average for software companies is 30.58X. For comparison, Salesforce.com (CRM) has a higher forward P/E of 74.88X.

Twenty-three of the 35 analysts who cover Citrix rated it buy. Eleven analysts gave the stock a hold rating and one rated it sell.

TheStreet Ratings gives Citrix an A- grade with a buy rating and $90.32 price target. The stock has risen 42.89% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs